
Orbion Pharmaceuticals Private Limited
Founded in 2021 and headquartered in Tamil Nadu, India.
Founded in 2021 and headquartered in Tamil Nadu, India.
Orbion Pharmaceuticals Private Limited (OPPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 31 May 2021 (Three years and 11 months 25 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 175.00 Cr and a paid-up capital of Rs 175.00 Cr.
The company currently has active open charges totaling ₹35.00 Cr.
The Key Managerial Personnel (KMP) at Orbion Pharmaceuticals Private Limited India is Sakthivel Ganapathy as COMPANY SECRETARY. Phanindranath Punji, Ashok Hegde, Mridul Dhanuka, and One other member serve as directors at the Company.
Kanchipuram, Tamil Nadu, India
+91-XXXXXXXXXX
U24100TN2021FTC143806
143806
Private Limited Foreign Company Incorporated In India
31 May 2021
25 Sep 2024
31 Mar 2024
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sakthivel Ganapathy | Company Secretary | 06-Oct-2022 | Current |
Ashok Hegde ![]() | Managing Director | 31-May-2021 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mridul Dhanuka ![]() | Director | 31-May-2021 | Current |
Phanindranath Punji ![]() | Director | 17-Aug-2021 | Current |
Bajrang Garg ![]() | Director | 17-Aug-2021 | Current |
Orbion Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2023, Orbion Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Phanindranath Punji and Ashok Hegde are mutual person
Mridul Dhanuka is a mutual person
Mridul Dhanuka is a mutual person
Mridul Dhanuka is a mutual person
Mridul Dhanuka is a mutual person
₹35.00 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
17 Jul 2023 | Hdfc Bank Limited | ₹35.00 Cr | Open |
Orbion Pharmaceuticals has a workforce of 250 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Orbion Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orbion Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Orbion Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
A charge with Hdfc Bank Limited of Rs. 35.00 Cr registered on 17 Jul 2023 with Charge ID 100750600 was modified on 14 Jun 2024.
Orbion Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
A charge with Hdfc Bank Limited amounted to Rs. 35.00 Cr with Charge ID 100750600 was registered on 17 Jul 2023.
Sakthivel Ganapathy was appointed as a Company Secretary was appointed as a Company Secretary on 06 Oct 2022 & has been associated with this company since 2 years 7 months .
Phanindranath Ramachandran Punji was appointed as a Director was appointed as a Director on 17 Aug 2021 & has been associated with this company since 3 years 9 months .
Orbion Pharmaceuticals Private Limited was incorporated on 31 May 2021.
The authorized share capital of Orbion Pharmaceuticals Private Limited is ₹ 175.00 Cr and paid-up capital is ₹ 175.00 Cr.
Currently 5 directors are associated with Orbion Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Orbion Pharmaceuticals Private Limited is Plot B5 (Part) B6 (Part) Sipcot Industrial Park Irrungatukottai Sriperumbudur Tal Uk, India, Kanchipuram, Tamil Nadu, 602117.
The corporate identification number (CIN) of Orbion Pharmaceuticals Private Limited is U24100TN2021FTC143806 and the company number is 143806 as per Ministry of Corporate Affairs (MCA).
As Per 2022 financial reports, 250 employees are currently employed by Orbion Pharmaceuticals Private Limited.
As per the financial statements for fiscal Year 2022, The total open charges for Orbion Pharmaceuticals Private Limited amount to ₹ 35.00 Cr.
The most recent Balance Sheet for Orbion Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.